$PFX
PhenixFIN Corp Stock $pfx

$pfx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024041496 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.980M	$571.3K	$4.912M
YoY Change	62.46%	-88.37%	34.32%
Cost Of Revenue	$1.722M	$1.567M	$1.382M
YoY Change	21.67%	13.44%	13.15%
Gross Profit	$4.513M	$3.092M	$3.531M
YoY Change	31.82%	-12.44%	44.94%
Gross Profit Margin	227.92%	541.12%	71.88%
Selling, General & Admin	$2.533M	$2.520M	$1.756M
YoY Change	14.89%	43.49%	36.58%
% of Gross Profit	56.13%	81.52%	49.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$127.0K
YoY Change	53.01%
% of Gross Profit	2.81%
Operating Expenses	$2.533M	$2.520M	$1.756M
YoY Change	14.89%	43.49%	36.58%
Operating Profit	$1.980M	$571.3K	$1.775M
YoY Change	62.46%	-67.8%	54.27%
Interest Expense	$1.722M	$1.567M	$4.934M
YoY Change	-77.63%	-68.24%	170.72%
% of Operating Profit	86.96%	274.28%	278.03%
Other Income/Expense, Net	$200.0K	$200.0K	$200.0K
YoY Change	0.0%	0.0%
Pretax Income	$2.609M	$5.372M	$6.708M
YoY Change	-70.74%	-19.91%	125.66%
Income Tax
% Of Pretax Income
Net Earnings	$2.609M	$5.372M	$6.708M
YoY Change	-70.74%	-19.91%	125.66%
Net Earnings / Revenue	131.76%	940.33%	136.56%
Basic Earnings Per Share	$1.29	$2.62	$3.20
Diluted Earnings Per Share	$1.29	$2.62	$3.20
COMMON SHARES
Basic Shares Outstanding	2.020M shares	2.060M shares	2.097M shares
Diluted Shares Outstanding	2.020M shares	2.049M shares	2.095M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.0M	$19.12M	$10.76M
YoY Change	846.91%	77.67%	-71.43%
Cash & Equivalents	$8.900M	$19.10M	$10.76M
Short-Term Investments	$94.09M
Other Short-Term Assets	$101.1K	$132.3K	$124.3K
YoY Change	783.92%	6.41%
Inventory
Prepaid Expenses
Receivables	$1.715M	$920.8K	$725.7K
Other Receivables	$206.0K		$662.9K
Total Short-Term Assets	$11.56M	$25.75M	$12.28M
YoY Change	-6.63%	109.72%	-68.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$353.4K	$385.1K	$444.5K
YoY Change	-14.01%	-13.38%	-25.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$233.7M	$220.0M	$200.1M
YoY Change	6.86%	9.98%	5.71%
Other Assets	$410.6K	$1.174M	$848.3K
YoY Change	-33.29%	38.35%
Total Long-Term Assets	$234.7M	$221.9M	$201.7M
YoY Change	6.67%	10.06%	5.97%
TOTAL ASSETS
Total Short-Term Assets	$11.56M	$25.75M	$12.28M
Total Long-Term Assets	$234.7M	$221.9M	$201.7M
Total Assets	$246.3M	$247.7M	$213.9M
YoY Change	5.96%	15.78%	-6.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.808M	$7.843M	$1.366M
YoY Change	187.79%	473.97%	-86.83%
Accrued Expenses	$847.1K	$1.085M	$1.172M
YoY Change	-25.25%	-7.44%	6.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.799M	$9.003M	$3.567M
YoY Change	-17.79%	152.37%	-69.12%
LONG-TERM LIABILITIES
Long-Term Debt	$85.29M	$84.42M	$78.88M
YoY Change	1.59%	7.03%	1.44%
Other Long-Term Liabilities		$0.00	$337.3K
YoY Change		-100.0%	-9.5%
Total Long-Term Liabilities	$85.29M	$84.42M	$79.21M
YoY Change	1.28%	6.57%	1.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.799M	$9.003M	$3.567M
Total Long-Term Liabilities	$85.29M	$84.42M	$79.21M
Total Liabilities	$92.09M	$93.42M	$82.78M
YoY Change	-0.43%	12.85%	-8.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$538.2M	-$538.2M
YoY Change	0.61%
Common Stock	$692.4M	$692.5M
YoY Change	2.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$154.2M	$154.3M	$131.2M
YoY Change
Total Liabilities & Shareholders Equity	$246.3M	$247.7M	$213.9M
YoY Change	5.96%	15.78%	-6.62%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$2.609M	$5.372M	$6.708M
YoY Change	-70.74%	-19.91%	125.66%
Depreciation, Depletion And Amortization	$127.0K
YoY Change	53.01%
Cash From Operating Activities	-$8.320M	$8.959M	-$6.646M
YoY Change	74.25%	-234.79%	-23.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.937M	-2.009M	-244.0K
YoY Change	-139.64%	723.29%	-98.12%
NET CHANGE
Cash From Operating Activities	-8.320M	8.959M	-6.646M
Cash From Investing Activities
Cash From Financing Activities	-1.937M	-2.009M	-244.0K
Net Change In Cash	-10.26M	6.950M	-6.890M
YoY Change	-9222.44%	-200.86%	-68.25%
FREE CASH FLOW
Cash From Operating Activities	-$8.320M	$8.959M	-$6.646M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	2.62
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2048622	shares
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-35040
	dei	Entity Registrant Name EntityRegistrantName	PHENIXFIN CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4576073
	dei	Entity Address Address Line1 EntityAddressAddressLine1	445 Park Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	859-0390
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2019790	shares
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	220049334	usd
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	226460691	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19123796	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	920769	usd
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	971115	usd
CY2024Q1	us-gaap	Dividends Receivable DividendsReceivable	243302	usd
CY2023Q3	us-gaap	Dividends Receivable DividendsReceivable	161479	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	31425	usd
CY2024Q1	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	5326933	usd
CY2023Q3	pfx	Due From Affiliates Amount DueFromAffiliatesAmount	409214	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1173608	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	833000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	724568	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	699124	usd
CY2024Q1	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	132295	usd
CY2023Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	199019	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	3940175	usd
CY2024Q1	us-gaap	Assets Assets	247694605	usd
CY2023Q3	us-gaap	Assets Assets	239693465	usd
CY2024Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1522586	usd
CY2023Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1688835	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	84419355	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	84253106	usd
CY2024Q1	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	5036284	usd
CY2023Q3	pfx	Payable For Investments Purchased PayableForInvestmentsPurchased	4123059	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2707303	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3066984	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	724564	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	690398	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	360477	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	432698	usd
CY2024Q1	pfx	Due To Affiliate DueToAffiliate	99725	usd
CY2024Q1	pfx	Administrator Expenses Payable AdministratorExpensesPayable	75000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	421685	usd
CY2024Q1	us-gaap	Liabilities Liabilities	93422708	usd
CY2023Q3	us-gaap	Liabilities Liabilities	92987930	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2020490	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2073713	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2021	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2074	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	692472513	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	694812239	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-538202637	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-548108778	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154271897	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	247694605	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	239693465	usd
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	76.35
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2024Q1	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	1950898	usd
CY2023Q1	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	2116741	usd
	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	4633041	usd
	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	4032782	usd
CY2024Q1	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	90530	usd
CY2023Q1	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	119593	usd
	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	181204	usd
	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	225780	usd
CY2024Q1	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	276484	usd
CY2023Q1	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	261028	usd
	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	732176	usd
	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	459481	usd
CY2024Q1	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	294028	usd
CY2023Q1	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	57188	usd
	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	580266	usd
	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	251815	usd
CY2024Q1	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	118864	usd
CY2023Q1	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	155994	usd
	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	268831	usd
	pfx	Payment In Kind Interest Income On Controlled Investments PaymentInKindInterestIncomeOnControlledInvestments	245737	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2730804	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2710544	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6395518	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5215595	usd
CY2024Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1652262	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1503375	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	3665988	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	3535733	usd
CY2024Q1	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	199266	usd
CY2023Q1	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	125471	usd
	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	240374	usd
	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	217697	usd
CY2024Q1	us-gaap	Fee Income FeeIncome	76517	usd
CY2023Q1	us-gaap	Fee Income FeeIncome	171055	usd
	us-gaap	Fee Income FeeIncome	78625	usd
	us-gaap	Fee Income FeeIncome	244654	usd
CY2023Q1	us-gaap	Other Income OtherIncome	401986	usd
	us-gaap	Other Income OtherIncome	22	usd
	us-gaap	Other Income OtherIncome	401986	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4658849	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4912431	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	10380527	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	9615665	usd
CY2024Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1567352	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1381596	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3109413	usd
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2614772	usd
CY2024Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1524508	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	802090	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2949500	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1659623	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	310776	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	201181	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	635837	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	421158	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	343150	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	377229	usd
	us-gaap	Professional Fees ProfessionalFees	700704	usd
	us-gaap	Professional Fees ProfessionalFees	725146	usd
CY2024Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	187500	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	176500	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	375000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	370500	usd
CY2024Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	96694	usd
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	121387	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	194450	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	245471	usd
CY2024Q1	pfx	Administrative Services Expense AdministrativeServicesExpense	57550	usd
CY2023Q1	pfx	Administrative Services Expense AdministrativeServicesExpense	77937	usd
	pfx	Administrative Services Expense AdministrativeServicesExpense	135402	usd
	pfx	Administrative Services Expense AdministrativeServicesExpense	155821	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4087530	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3137920	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	8100306	usd
	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	6192491	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	571319	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	1774511	usd
	us-gaap	Net Investment Income NetInvestmentIncome	2280221	usd
	us-gaap	Net Investment Income NetInvestmentIncome	3423174	usd
CY2024Q1	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	200754	usd
CY2023Q1	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	-838070	usd
	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	430558	usd
	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	-824622	usd
CY2024Q1	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	-1991456	usd
	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	-1991456	usd
CY2023Q1	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	23273	usd
	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	23273	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1790702	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-814797	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1560898	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-801349	usd
CY2024Q1	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1796767	usd
CY2023Q1	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	803513	usd
	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	3161010	usd
	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	2326612	usd
CY2024Q1	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	2282655	usd
CY2023Q1	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	274063	usd
	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	4713918	usd
	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	989600	usd
CY2024Q1	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	2512263	usd
CY2023Q1	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	4670928	usd
	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	1311890	usd
	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	4722097	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6591685	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5748504	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9186818	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8038309	usd
CY2024Q1	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	4800983	usd
CY2023Q1	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	4933707	usd
	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	7625920	usd
	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	7236960	usd
CY2024Q1	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	5372302	usd
CY2023Q1	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	6708218	usd
	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	9906141	usd
	pfx	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	10660134	usd
CY2024Q1	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	2.62
CY2023Q1	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	3.2
	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	4.81
	pfx	Weighted Average Basic Earnings Per Share WeightedAverageBasicEarningsPerShare	5.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2048622	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095193	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2060723	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2098041	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	124692805	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	1774511	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-814797	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5748504	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	250134	usd
CY2023Q1	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-6458084	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	131150889	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	150700800	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	571319	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1790702	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6591685	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1801205	usd
CY2024Q1	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-3571097	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154271897	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	120845408	usd
	us-gaap	Net Investment Income NetInvestmentIncome	3423174	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-801349	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8038309	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	354653	usd
	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-10305481	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	131150889	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	146705535	usd
	us-gaap	Net Investment Income NetInvestmentIncome	2280221	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1560898	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	9186818	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2339779	usd
	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	-7566362	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	154271897	usd
	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	9906141	usd
	pfx	Net Increasedecrease In Net Assets Resulting From Operations Amount NetIncreasedecreaseInNetAssetsResultingFromOperationsAmount	10660134	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	45595165	usd
	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	26919844	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	30835453	usd
	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	25975213	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	450035	usd
	us-gaap	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	471517	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	272400	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	368824	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	166249	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	204079	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	212333	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	113963	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1560898	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-801349	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	9186818	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	8038309	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-50346	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1927	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	4917719	usd
	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	121627	usd
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold	-3940175	usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	81823	usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	-112500	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-31425	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-36992	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-66724	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-364828	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	340608	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-474188	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-16550000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	913225	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	1026818	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-359681	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-673784	usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	99725	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-75000	usd
	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	73011	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	34166	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	170169	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-421685	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	9905	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-72221	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-72188	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15713129	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11447777	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	23241941	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	22521800	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9751	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	237777	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	912275	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2339779	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	354653	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2577556	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-556538	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13135573	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12004315	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5988223	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19123796	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10763751	usd
	us-gaap	Interest Paid Net InterestPaidNet	2667051	usd
	us-gaap	Interest Paid Net InterestPaidNet	1854240	usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments	11900000	usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments	11900000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates in the Preparation of Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19100000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6000000	usd
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</p>
	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis. Discounts and premiums to par value on investments purchased are accreted and amortized into interest income over the life of the respective investment. Loan origination fees, original issue discount (“OID”) and market discounts or premiums are capitalized and amortized into interest income using the effective interest method or straight-line method, as applicable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is recorded on the accrual basis to the extent such amounts are expected to be collected. PIK interest is not accrued if the Company does not expect the issuer to be able to pay all principal and interest when due. For the three and six months ended March 31, 2024, the Company earned approximately $0.2 million and $0.5 million in PIK interest, respectively. For the three and six months ended March 31, 2023, the Company earned approximately $0.3 million and $0.5 million in PIK interest, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amendment and transaction break-up fees associated with investments in portfolio companies are recognized as income when we become entitled to such fees. Prepayment penalties received by the Company for debt instruments paid back to the Company prior to the maturity date are recorded as income upon repayment of debt. Administrative agent fees received by the Company are capitalized as deferred revenue and recorded as fee income when the services are rendered. For the three and six months ended March 31, 2024, fee income was approximately $0.1 million and approximately $0.1 million, respectively (see Note 9). For the three and six months ended March 31, 2023, fee income was approximately $0.2 million and $0.2 million, respectively (see Note 9).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment transactions are accounted for on a trade date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment using the specific identification method, without regard to unrealized gains or losses previously recognized. No losses relating to restructuring transactions occurred during the three and six months ended March 31, 2024 and 2023. Realized gains relating to restructuring transactions that occurred during the three and six months ended March 31, 2024 were $6.9 million and $6.9 million, respectively. No gains relating to restructuring transactions occurred during the three and six months ended March 31, 2023. The Company reports changes in fair value of investments as net unrealized appreciation/(depreciation) on investments in the Consolidated Statements of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management reviews all loans that become 90 days or more past due on principal or interest or when there is reasonable doubt that principal or interest will be collected for possible placement on management’s designation of non-accrual status. Interest receivable is analyzed regularly and may be reserved against when deemed not collectible. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At March 31, 2024, certain investments in three portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $21.1 million, or 9.6% of the fair value of our portfolio. At September 30, 2023, certain investments in four portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $6.5 million, or 2.9% of the fair value of our portfolio.</p>
CY2023Q1	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	300000	usd
	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	500000	usd
CY2024Q1	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	100000	usd
	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	100000	usd
CY2024Q1	pfx	Realized Gains RealizedGains	6900000	usd
	pfx	Realized Gains RealizedGains	6900000	usd
CY2024Q1	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	21100000	usd
	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.096	pure
CY2023Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	6500000	usd
CY2023Q3	pfx	Portfolio Percentage At Fair Values PortfolioPercentageAtFairValues	0.029	pure
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	220049000	usd
CY2024Q1	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentages Of Net Assets InvestmentOwnedPercentagesOfNetAssets	1	pure
	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23800000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23100000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23800000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23100000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately. </p>
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	133100	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206500	usd
CY2024Q1	pfx	Unrealized Depreciation Related To Warrants UnrealizedDepreciationRelatedToWarrants	95500	usd
	pfx	Unrealized Depreciation Related To Warrants UnrealizedDepreciationRelatedToWarrants	73300	usd
CY2023Q1	pfx	Unrealized Depreciation Related To Warrants UnrealizedDepreciationRelatedToWarrants	210200	usd
	pfx	Unrealized Depreciation Related To Warrants UnrealizedDepreciationRelatedToWarrants	147600	usd
CY2024Q1	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	220049000	usd
CY2024Q1	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
CY2023Q3	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	226461000	usd
CY2023Q3	pfx	Investment Owned Percentage Of Net Assets InvestmentOwnedPercentageOfNetAssets	1	pure
	us-gaap	Investment Income Net InvestmentIncomeNet	2173000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	4385000	usd
	us-gaap	Operating Expenses OperatingExpenses	448000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	815000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1725000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3570000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	165316000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	34450000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-53752000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-1472000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	5995000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	150537000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	25193000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-24305000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	-837000	usd
	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Changes In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangesInUnrealizedGainLoss	4540000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	151266000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3400000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2400000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	150537000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	165316000	usd
CY2024Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	593000	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	353000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1191000	usd
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	353000	usd
CY2024Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	17000	usd
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2024Q1	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2023Q3	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	0	usd
CY2018Q1	pfx	Asset Coverage Percentage With No Approval AssetCoveragePercentageWithNoApproval	2	pure
CY2024Q1	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.795	pure
CY2023Q3	pfx	Asset Coverage Percentage AssetCoveragePercentage	2.707	pure
CY2024Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	91558000	usd
CY2024Q1	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	85942000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	84419000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	80399000	usd
CY2023Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	79058000	usd
CY2023Q3	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	85942000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	84253000	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	77547000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	28400000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2023Q1	us-gaap	Securities Borrowed SecuritiesBorrowed	23200000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22600000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	22521800	usd
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	1	pure
CY2023Q3	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	31000	usd
CY2024Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	121000	usd
CY2023Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	84000	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	213000	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	114000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	82000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	101000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	166000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	204000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1567000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1382000	usd
	us-gaap	Interest Expense InterestExpense	3109000	usd
	us-gaap	Interest Expense InterestExpense	2615000	usd
CY2024Q1	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.063	pure
CY2023Q1	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.06	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.063	pure
	pfx	Weighted Average Stated Interest Rate WeightedAverageStatedInterestRate	0.057	pure
CY2024Q1	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	85942000	usd
CY2023Q1	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	80606000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	85942000	usd
	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	80311000	usd
CY2024Q1	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	504890	usd
	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	809690	usd
	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3113000	usd
CY2023	pfx	Investment Company Unfunded Commitment InvestmentCompanyUnfundedCommitment	3375000	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	78239	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156971	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161680	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27417	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	424307	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	63830	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	360477	usd
CY2024Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	75000	usd
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	75000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	75000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	75000	usd
CY2024Q1	us-gaap	Payments For Fees PaymentsForFees	2000	usd
CY2023Q1	us-gaap	Payments For Fees PaymentsForFees	96000	usd
	us-gaap	Payments For Fees PaymentsForFees	4000	usd
	us-gaap	Payments For Fees PaymentsForFees	170000	usd
CY2024Q1	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	77000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	171000	usd
	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	79000	usd
	us-gaap	Interest And Fee Income Loans Commercial InterestAndFeeIncomeLoansCommercial	245000	usd
CY2024Q1	us-gaap	Other Expenses OtherExpenses	200000	usd
	us-gaap	Other Expenses OtherExpenses	400000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	200000	usd
	us-gaap	Other Expenses OtherExpenses	400000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5372000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6708000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	9906000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10660000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2048622	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2095193	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2060723	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2098041	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.62
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.81
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.08
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	70.75
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.11
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.63
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-0.76
	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	-0.38
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	4.46
	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	3.83
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	4.81
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	5.08
	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.79
	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.13
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.79
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.13
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	76.35
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	62.7
CY2024Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	154271897	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	131150889	usd
CY2024Q1	us-gaap	Shares Outstanding SharesOutstanding	2020490	shares
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	2091638	shares
CY2024Q1	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	44.1
CY2023Q1	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	37
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.1636	pure
	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	0.0608	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0516	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0906	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.1383	pure
	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.137	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0308	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0547	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1095	pure
	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.099	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0076	pure
	pfx	Investment Company Investment Income Percentage Of Nonrecurring Fee Income InvestmentCompanyInvestmentIncomePercentageOfNonrecurringFeeIncome	0.0254	pure
	pfx	Average Debt Outstanding AverageDebtOutstanding	85941941	shares
	pfx	Average Debt Outstanding AverageDebtOutstanding	80310648	shares
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	41.7
	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	38.33
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2795	usd
	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2663	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28441941	usd
	pfx	Supplemental Data Credit Facility SupplementalDataCreditFacility	28241941	usd
CY2024Q1	pfx	Asset Coverage Of Indebtedness AssetCoverageOfIndebtedness	1000	usd
CY2024Q1	us-gaap	Investment Company Senior Security Stock Asset Coverage Ratio InvestmentCompanySeniorSecurityStockAssetCoverageRatio	2.795	pure
CY2024Q1	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	2	pure
CY2021Q1	srt	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	703219	shares
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	28100000	usd
CY2024Q1	pfx	Percentage Of Shares Outstanding PercentageOfSharesOutstanding	0.258	pure
CY2024Q1	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	6900000	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	39.93
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	703219	shares
	pfx	Stock Repurchased And Retired During Period Values StockRepurchasedAndRetiredDuringPeriodValues	28077265	usd
	pfx	Stock Transferred To Treasury Stock StockTransferredToTreasuryStock	53348	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	125	shares
CY2024Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	84000000	shares
CY2024Q2	pfx	Percentage Of Outstanding Shares PercentageOfOutstandingShares	0.44	pure
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.05
	pfx	Percentage Of Membership Units PercentageOfMembershipUnits	1	pure
CY2024Q2	pfx	Company Issued Percentage CompanyIssuedPercentage	0.0525	pure
CY2024Q2	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	1661498	usd
CY2024Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	1.31
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q3	pfx	Due To Affiliate DueToAffiliate		usd
CY2023Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable		usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
CY2023Q1	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments		usd
CY2024Q1	us-gaap	Other Income OtherIncome		usd
CY2023Q1	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments		usd
	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments		usd
CY2024Q1	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2023Q1	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	3.20
	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	4.81
	pfx	Weighted Average Diluted Earnings Per Share WeightedAverageDilutedEarningsPerShare	5.08
	us-gaap	Increase Decrease In Receivable For Investment Sold IncreaseDecreaseInReceivableForInvestmentSold		usd
	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable		usd
	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	pfx	Noncash Purchase Of Investments NoncashPurchaseOfInvestments		usd
	pfx	Noncash Sale Of Investments NoncashSaleOfInvestments		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2023Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts		usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2024Q1	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2023Q1	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2024Q1	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2023Q1	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2048622	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2060723	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2095193	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2098041	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.62
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.08
	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax
	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001490349

Files In Submission

Name	View Source	Status
0001213900-24-041496-index-headers.html	Edgar Link	pending
0001213900-24-041496-index.html	Edgar Link	pending
0001213900-24-041496.txt	Edgar Link	pending
0001213900-24-041496-xbrl.zip	Edgar Link	pending
ea0205196-10q_phenixfin.htm	Edgar Link	pending
ea020519601ex10-13_phenixfin.htm	Edgar Link	pending
ea020519601ex31-1_phenixfin.htm	Edgar Link	pending
ea020519601ex31-2_phenixfin.htm	Edgar Link	pending
ea020519601ex32-1_phenixfin.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfx-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pfx-20240331_cal.xml	Edgar Link	unprocessable
pfx-20240331_def.xml	Edgar Link	unprocessable
pfx-20240331_lab.xml	Edgar Link	unprocessable
pfx-20240331_pre.xml	Edgar Link	unprocessable
ea0205196-10q_phenixfin_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFX
PhenixFIN Corp Stock $pfx

2024 Q2 Form 10-Q Financial Statement

#000121390024041496 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX PhenixFIN Corp Stock $pfx

2024 Q2 Form 10-Q Financial Statement

#000121390024041496 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX
PhenixFIN Corp Stock $pfx